跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,788 条关于
“Roivant Sciences”
全部
4,788
临床试验
419
药物
574
机构
576
资讯
3,219
去年
Roivant Sciences Gains Orphan Drug Designation in Japan for Mosliciguat in Pulmonary Hypertension
2年前
Roivant Acquires Mosliciguat from Bayer for Pulmonary Hypertension Treatment
2年前
Roivant Launches Pulmovant with In-Licensed Bayer Drug for Pulmonary Hypertension
去年
Organon Expands Dermatology Portfolio with $1.2 Billion Acquisition of Dermavant
9个月前
Roivant Accelerates Pipeline Timelines with Multiple Late-Stage Programs Advancing Toward Market
去年
FDA Extends Review of Organon's Vtama for Atopic Dermatitis to March
去年
Enzyvant's RVT-802 Receives Landmark Dual Fast-Track Status from FDA for Complete DiGeorge Syndrome
去年
Immunovant Shifts Focus to Next-Gen Therapy Despite Positive Phase III Results for Batoclimab in Myasthenia Gravis
2年前
Court Rules in Favor of Arbutus in Patent Dispute Over Moderna's COVID-19 Vaccine Delivery Technology
7个月前
Pulmovant Completes Enrollment in Phase 2 Trial of Mosliciguat for Pulmonary Hypertension Associated with Interstitial Lung Disease
第 1 页,共 322 页
上一页
下一页